A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model

• Víctor Alfonso Solarte,

  Affiliation Cellular and Molecular Physiology Group, Biomedical Research Institute, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia

  ⨯
• Paulette Conget,

  Affiliation Center for Regenerative Medicine, School of Medicine Clínica Alemana Universidad del Desarrollo, Lo Barnechea, Santiago, Chile

  ⨯
• Jean-Paul Vernot,

  Affiliation Cellular and Molecular Physiology Group, Biomedical Research Institute, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia

  ⨯
• Jaiver Eduardo Rosas,

  Affiliation Department of Pharmacy, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá, Colombia

  ⨯
• Zuly Jenny Rivera,

  Affiliation Department of Chemistry, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá, Colombia

  ⨯
• Javier Eduardo García,

  Affiliation Department of Pharmacy, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá, Colombia

  ⨯
• Martha Ligia Arango-Rodríguez

  * E-mail: martha.arango@foscal.com.co

  Affiliation Banco Multitejidos y Centro de Terapias Avanzadas, Fundación Ofalmológica de Santander, Clínica Carlos Ardila Lulle (FOSCAL Internacional), Bucaramanga, Colombia

  ⨯